MR. DAVID DONALD CAMPBELL, P.T.
Physical Therapy at Greenmeadow Way, Palo Alto, CA
License number
California 17642
Category
Restorative Service Providers
Type
Physical Therapist
Address
Address
244 Greenmeadow Way, Palo Alto, CA 94306
Phone
(415) 225-9307
Professional information
Devops - Site Reliability At Nest Labs
Position:
DevOps - Site Reliability at Nest Labs
Location:
San Francisco Bay Area
Industry:
Computer Software
Work:
Nest Labs
- Palo Alto, CA since Nov 2012
-
DevOps - Site Reliability
24/7, Inc
- Campbell, CA Aug 2012 - Nov 2012
-
Senior Systems Engineer, Infrastructure Engineering
24/7, Inc
- Campbell, CA May 2012 - Sep 2012
-
Systems Engineer
Tellme Networks
Mar 2009 - May 2012
-
Service Engineer
Microsoft
Mar 2009 - May 2012
-
Service Engineer
InfoStreet
Jan 2008 - Jan 2009
-
Systems Administrator
OC3 Networks
Sep 2007 - Jan 2008
-
Linux Consultant
Priority Financial Network
2007 - 2008
-
Systems Administrator
Education:
Drake University 2004 - 2005
Mount Ayr Community High School 2000 - 2004
Mount Ayr Community High School 2000 - 2004
Skills:
Monitoring, Automation, Unix, Solaris, Perl, Shell Scripting, Ruby, Scalability, Integration, MySQL, Linux, Databases, Solo Formation Flying, Ruby on Rails, Infrastructure, Remediation
Associate Director At Mark One Capital
Position:
Associate Director at Mark One Capital
Location:
San Francisco Bay Area
Industry:
Real Estate
Work:
Mark One Capital
- Palo Alto, CA since Nov 2007
-
Associate Director
Education:
Cornell University 2002 - 2006
BA, Economics & American Studies
BA, Economics & American Studies
Skills:
Real Estate Economics, Real Estate Development, Real Estate, Real Estate Transactions, Investment Properties
David D Campbell, Palo Alto CA - PT (Physical therapy)
Specialties:
Physical Therapy
Address:
244 Greenmeadow Way, Palo Alto 94306
Languages:
English
Vaccines For Equine Influenza
US Patent:
4693893, Sep 15, 1987
Filed:
Apr 3, 1984
Appl. No.:
6/596447
Inventors:
David A. Campbell - Palo Alto CA
Assignee:
Burroughs Wellcome - NC
International Classification:
A61K 39155, A61K 39295
US Classification:
424 89
Abstract:
It is known that the human influenza virus strain A/Puerto Rico/8/34 grows particularly well in eggs and that reassorted viruses having it as a parent may also grow well in eggs. It has now been found that certain reassortants of A/PR/8/34 and equine influenza viruses, namely those which comprise the RNA7 segment from A/PR/8/34, will grow in cell culture, even though the parent equine influenza vius will not.
Thus the specification describes and claims: reassorted viruses comprising genes for surface antigens of equine influenza viruses and the RNA7 segment from A/PR/8/34; methods of obtaining such viruses by reassortment; methods of propagating such reassorted viruses in cell culture, especially Vero cells; vaccines against equine influenza comprising such reassorted viruses; and methods of vaccinating equines against influenza.
5-Fluorouridine Nucleoside Phosphate Compounds
US Patent:
5302707, Apr 12, 1994
Filed:
Mar 26, 1992
Appl. No.:
7/858298
Inventors:
David A. Campbell - East Palo Alto CA
Mark A. Gallop - East Palo Alto CA
Mark A. Gallop - East Palo Alto CA
Assignee:
Affymax Technologies N.V. - Palo Alto CA
International Classification:
C07H 1906
US Classification:
536 2533
Abstract:
Compositions and methods for producing the activating moiety of a site-directed catalytic antibody are provided. The activating moiety serves to enhance the rate of chemical reactions involving the conversion of the prodrug to one or more active substrates or drugs. The activating moiety typically comprises a catalytic antibody. Compositions and methods for producing the catalytic antibodies, as well as the haptens which are used to generate the catalytic antibodies, are provided. Compositions and methods for producing the prodrugs are also provided.
Vaccines For Equine Influenza
US Patent:
6045790, Apr 4, 2000
Filed:
Sep 1, 1992
Appl. No.:
7/939556
Inventors:
David Andrew Campbell - Palo Alto CA
International Classification:
A01N 6300, C12N 700, C12N 702, C12N 704
US Classification:
424 933
Abstract:
It is known that the human influenza virus strain A/Puerto Rico/8/34 grows particularly well in eggs and that reasserted viruses having it as a parent may also grow well in eggs. It has now been found that certain reassortants of A/PR/8/34 and equine influenza viruses, namely those which comprise the RNA7 segment from A/PR/8/34, will grow in cell culture, even though the parent equine influenza virus will not.
Thus the specification describes and claims: reassorted viruses comprising genes for surface antigens of equine influenza viruses and the RNA7 segment from A/PR/8/34; methods of obtaining such viruses by reassortment; methods of propagating such reasserted viruses in cell culture, especially Vero cells; vaccines against equine influenza comprising such reassorted viruses; and methods of vaccinating equines against influenza.